Use of antipsychotic medications in older home-care patients. Report from nine European countries

To access publisher full text version of this article. Please click on the hyperlink in Additional Links field BACKGROUND AND AIMS: Data on the use of antipsychotics among older people in need of regular home care services are rare. The aim of this study was to ascertain the differences in the use a...

Full description

Bibliographic Details
Main Authors: Alanen, Hanna-Mari, Finne-Soveri, Harriet, Fialova, Daniela, Topinkova, Eva, Jonsson, Palmi V, Soerbye, Liv Wergeland, Bernabei, Roberto, Leinonen, Esa
Other Authors: University of Tampere, Medical School, FIN- 33014 Tampere, Finland. hanna-mari.alanen@uta.fi
Format: Article in Journal/Newspaper
Language:English
Published: Editrice Kurtis 2008
Subjects:
Online Access:http://hdl.handle.net/2336/42335
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/42335
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/42335 2023-05-15T16:52:47+02:00 Use of antipsychotic medications in older home-care patients. Report from nine European countries Alanen, Hanna-Mari Finne-Soveri, Harriet Fialova, Daniela Topinkova, Eva Jonsson, Palmi V Soerbye, Liv Wergeland Bernabei, Roberto Leinonen, Esa University of Tampere, Medical School, FIN- 33014 Tampere, Finland. hanna-mari.alanen@uta.fi 2008-12-15 http://hdl.handle.net/2336/42335 en eng Editrice Kurtis http://www.kurtis.it/abs/index.cfm?id_articolo_numero=4666 Aging Clin Exp Res. 2008, 20(3):260-5 1594-0667 18594194 http://hdl.handle.net/2336/42335 Aging clinical and experimental research Aged 80 and over Antipsychotic Agents Europe Female Home Care Services Humans Logistic Models Male Time Factors Article 2008 ftlandspitaliuni 2022-05-29T08:21:13Z To access publisher full text version of this article. Please click on the hyperlink in Additional Links field BACKGROUND AND AIMS: Data on the use of antipsychotics among older people in need of regular home care services are rare. The aim of this study was to ascertain the differences in the use and type of antipsychotic medications between European home-care sites. METHODS: A cross-sectional study was designed by means of RAI (Resident Assessment Instrument for Home Care) assessments. A random sample of 3251 assessments was gathered during the period September 2001-January 2002 from home care patients aged 65 and over in nine European countries (Czech Republic, Denmark, Finland, Germany, Iceland, Italy, Netherlands, Norway and United Kingdom). RESULTS: Two hundred of the home care patients (6.2%) received antipsychotic medication. The prevalence of the use of one or more antipsychotics varied widely between study sites, ranging from 3.0% in Denmark to 12.4% in Finland. Factors independently associated with the use of antipsychotics were: delusions (OR 3.09, 95% CI 1.66-5.76), any diagnosis of dementia (OR 2.57, 95% CI 1.70-3.87), youngest age group (65-74 yrs) (OR 2.37, 95% CI 1.53-3.66) and hallucinations (OR 2.28, 95% CI 1.17-4.45). Concomitant use of anxiolytics (OR 2.32, 95% CI 1.58- 3.41), hypnotics (OR 2.08, 95% CI 1.44-3.03) and antidepressants (OR 2.06, 95% CI 1.41-3.00) together with signs of depression (OR 1.78, 95% CI 1.24- 2.56), moderate to severe cognitive impairment (OR 1.30, 95% CI 1.12-1.51) and residing in Finland (OR 2.52, 95% CI 1.21-5.24) or Italy (OR 2.15, 95% CI 1.10-4.19) were associated with the use of antipsychotics. The most commonly used antipsychotic agent was risperidone (n=42, 21%). CONCLUSIONS: The frequency of antipsychotic drug use in older home-care patients varied considerably among the European countries studied. Antipsychotic drug treatment in older home-care recipients seems to be less common than in residents in long-term institutional care, and more common than among ... Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Norway
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language English
topic Aged
80 and over
Antipsychotic Agents
Europe
Female
Home Care Services
Humans
Logistic Models
Male
Time Factors
spellingShingle Aged
80 and over
Antipsychotic Agents
Europe
Female
Home Care Services
Humans
Logistic Models
Male
Time Factors
Alanen, Hanna-Mari
Finne-Soveri, Harriet
Fialova, Daniela
Topinkova, Eva
Jonsson, Palmi V
Soerbye, Liv Wergeland
Bernabei, Roberto
Leinonen, Esa
Use of antipsychotic medications in older home-care patients. Report from nine European countries
topic_facet Aged
80 and over
Antipsychotic Agents
Europe
Female
Home Care Services
Humans
Logistic Models
Male
Time Factors
description To access publisher full text version of this article. Please click on the hyperlink in Additional Links field BACKGROUND AND AIMS: Data on the use of antipsychotics among older people in need of regular home care services are rare. The aim of this study was to ascertain the differences in the use and type of antipsychotic medications between European home-care sites. METHODS: A cross-sectional study was designed by means of RAI (Resident Assessment Instrument for Home Care) assessments. A random sample of 3251 assessments was gathered during the period September 2001-January 2002 from home care patients aged 65 and over in nine European countries (Czech Republic, Denmark, Finland, Germany, Iceland, Italy, Netherlands, Norway and United Kingdom). RESULTS: Two hundred of the home care patients (6.2%) received antipsychotic medication. The prevalence of the use of one or more antipsychotics varied widely between study sites, ranging from 3.0% in Denmark to 12.4% in Finland. Factors independently associated with the use of antipsychotics were: delusions (OR 3.09, 95% CI 1.66-5.76), any diagnosis of dementia (OR 2.57, 95% CI 1.70-3.87), youngest age group (65-74 yrs) (OR 2.37, 95% CI 1.53-3.66) and hallucinations (OR 2.28, 95% CI 1.17-4.45). Concomitant use of anxiolytics (OR 2.32, 95% CI 1.58- 3.41), hypnotics (OR 2.08, 95% CI 1.44-3.03) and antidepressants (OR 2.06, 95% CI 1.41-3.00) together with signs of depression (OR 1.78, 95% CI 1.24- 2.56), moderate to severe cognitive impairment (OR 1.30, 95% CI 1.12-1.51) and residing in Finland (OR 2.52, 95% CI 1.21-5.24) or Italy (OR 2.15, 95% CI 1.10-4.19) were associated with the use of antipsychotics. The most commonly used antipsychotic agent was risperidone (n=42, 21%). CONCLUSIONS: The frequency of antipsychotic drug use in older home-care patients varied considerably among the European countries studied. Antipsychotic drug treatment in older home-care recipients seems to be less common than in residents in long-term institutional care, and more common than among ...
author2 University of Tampere, Medical School, FIN- 33014 Tampere, Finland. hanna-mari.alanen@uta.fi
format Article in Journal/Newspaper
author Alanen, Hanna-Mari
Finne-Soveri, Harriet
Fialova, Daniela
Topinkova, Eva
Jonsson, Palmi V
Soerbye, Liv Wergeland
Bernabei, Roberto
Leinonen, Esa
author_facet Alanen, Hanna-Mari
Finne-Soveri, Harriet
Fialova, Daniela
Topinkova, Eva
Jonsson, Palmi V
Soerbye, Liv Wergeland
Bernabei, Roberto
Leinonen, Esa
author_sort Alanen, Hanna-Mari
title Use of antipsychotic medications in older home-care patients. Report from nine European countries
title_short Use of antipsychotic medications in older home-care patients. Report from nine European countries
title_full Use of antipsychotic medications in older home-care patients. Report from nine European countries
title_fullStr Use of antipsychotic medications in older home-care patients. Report from nine European countries
title_full_unstemmed Use of antipsychotic medications in older home-care patients. Report from nine European countries
title_sort use of antipsychotic medications in older home-care patients. report from nine european countries
publisher Editrice Kurtis
publishDate 2008
url http://hdl.handle.net/2336/42335
geographic Norway
geographic_facet Norway
genre Iceland
genre_facet Iceland
op_relation http://www.kurtis.it/abs/index.cfm?id_articolo_numero=4666
Aging Clin Exp Res. 2008, 20(3):260-5
1594-0667
18594194
http://hdl.handle.net/2336/42335
Aging clinical and experimental research
_version_ 1766043169811595264